1 |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
|
2 |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(1): 7-30.
|
3 |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
4 |
Zhang H, Wang Z, Ma R, et al. MicroRNAs as biomarkers for the progression and prognosis of colon carcinoma[J]. Int J Mol Med, 2018, 42(4): 2080-2088.
|
5 |
Sun K, Han RJ, Han Y, et al. Accuracy of combined computed tomography colonography and dual energy iiodine map imaging for detecting colorectal masses using high-pitch dual-source CT[J]. Sci Rep, 2018, 8(1): 3790.
|
6 |
Thomsen M, Skovlund E, Sorbye H, et al. Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome[J]. Br J Cancer, 2018, 118(12): 1609-1616.
|
7 |
Gao Y, Wang J, Zhou Y, et al. Evaluation of serum CEA, CA19-9, CA72-4, CA125 and ferritin as diagnostic markers and factors of clinical parameters for colorectal cancer[J]. Sci Rep, 2018, 8(1): 2732.
|
8 |
Chen LL, Yang L. Regulation of circRNA biogenesis[J]. RNA Biol, 2015, 12(4): 381-388.
|
9 |
Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency[J]. Nature, 2013, 495(7441): 333-338.
|
10 |
Pamudurti NR, Bartok O, Jens M, et al. Translation of circRNAs[J]. Mol Cell, 2017, 66(1): 9-21.e7.
|
11 |
Barrett SP, Salzman J. Circular RNAs: analysis, expression and potential functions[J]. Dev Camb Engl, 2016, 143(11): 1838-1847.
|
12 |
Zhu Z, Rong Z, Luo Z, et al. Circular RNA circNHSL1 promotes gastric cancer progression through the miR-1306-3p/SIX1/vimentin axis[J]. Mol Cancer, 2019, 18(1): 126.
|
13 |
Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(3): 145-164.
|
14 |
Wang Y, Wang Z. Efficient backsplicing produces translatable circular mRNAs[J]. RNA, 2015, 21(2): 172-179.
|
15 |
Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats[J]. RNA, 2013, 19(2): 141-157.
|
16 |
Schwanhäusser B, Busse D, Li N, et al. Global quantification of mammalian gene expression control[J]. Nature, 2011, 473(7347): 337-342.
|
17 |
Vo JN, Cieslik M, Zhang YJ, et al. The landscape of circular RNA in cancer[J]. Cell, 2019, 176(4): 869-881.e13.
|
18 |
Zhu Z, Yu Z, Rong Z, et al. The novel GINS4 axis promotes gastric cancer growth and progression by activating Rac1 and CDC42[J]. Theranostics, 2019, 9(26): 8294-8311.
|
19 |
Li Y, Zheng QP, Bao CY, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis[J]. Cell Res, 2015, 25(8): 981-984.
|
20 |
Zhu P, Zhu X, Wu J, et al. IL-13 secreted by ILC2s promotes the self-renewal of intestinal stem cells through circular RNA circPan3[J]. Nat Immunol, 2019, 20(2): 183-194.
|
21 |
Li WL, Xu YQ, Wang XD, et al. circCCT3 modulates vascular endothelial growth factor A and Wnt signaling to enhance colorectal cancer metastasis through sponging miR-613[J]. DNA Cell Biol, 2020, 39(1): 118-125.
|
22 |
Zhong Z, Huang M, Lv M, et al. Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway[J]. Cancer Lett, 2017, 403: 305-317.
|
23 |
Liang WC, Wong CW, Liang PP, et al. Translation of the circular RNA circβ-catenin promotes liver cancer cell growth through activation of the Wnt pathway[J]. Genome Biol, 2019, 20(1): 84.
|
24 |
Zhi X, Zhang J, Cheng Z, et al. circLgr4 drives colorectal tumorigenesis and invasion through Lgr4-targeting peptide[J]. Int J Cancer, 2019. DOI:10.1002/ijc.32549.
|
25 |
Rong DW, Sun HD, Li ZX, et al. An emerging function of circRNA-miRNAs-mRNA axis in human diseases[J]. Oncotarget, 2017, 8(42): 73271-73281.
|
26 |
Gallí M, van Gool F, Rongvaux A, et al. The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer[J]. Cancer Res, 2010, 70(1): 8-11.
|
27 |
Garten A, Schuster S, Penke M, et al. Physiological and pathophysiological roles of NAMPT and NAD metabolism[J]. Nat Rev Endocrinol, 2015, 11(9): 535-546.
|
28 |
Sampath D, Zabka TS, Misner DL, et al. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer[J]. Pharmacol Ther, 2015, 151: 16-31.
|
29 |
Lucena-Cacace A, Otero-Albiol D, Jiménez-García MP, et al. NAMPT is a potent oncogene in colon cancer progression that modulates cancer stem cell properties and resistance to therapy through Sirt1 and PARP[J]. Clin Cancer Res, 2018, 24(5): 1202-1215.
|